COMMUNIQUÉS West-GlobeNewswire

SRX Global Acquires Stake in Vistagen Therapeutics (NASDAQ: VTGN)
04/08/2026
NORTH PALM BEACH, Fla., Aug. 04, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company”, or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value through investments [...]
Transactions in connection with share buy-back program
04/08/2026
Company announcement no. 28 - 26 04 August 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company [...]
AMSilk collaboration: Biotech silk protein yarns feature in Balenciaga 55th Couture Collection
04/08/2026
Haute Couture evening gown constructed using AMSilk-blend fabric Follows debut of AMSilk bioengineered silk protein yarns in Balenciaga Spring Collection 2026 NEURIED, Germany, Aug. 04, 2026 (GLOBE NEWSWIRE) -- AMSilk, [...]
Pharming Group to participate in Canaccord Genuity 46th Annual Growth Conference
04/08/2026
Leiden, the Netherlands, August 4, 2026: Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR), today announced its participation in the Canaccord Genuity 46 th Annual Growth Conference in Boston on August 12-13 [...]
Nurix Therapeutics Announces First Patient Enrolled in Registrational Phase 3 DAYBreak CLL-306 Trial of Bexobrutideg in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
04/08/2026
Phase 3 trial designed to demonstrate superiority of bexobrutideg versus pirtobrutinib in patients with relapsed/refractory CLL/SLL previously treated with a covalent BTK inhibitor BRISBANE, Calif., Aug. 04, 2026 (GLOBE [...]
Press Release: Sanofi’s MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease
04/08/2026
Sanofi’s MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease Paris, August 4, 2026. Sanofi today announced that the European Commission (EC) has approved an [...]
Communiqué de presse : MenQuadfi de Sanofi approuvé dans l’UE pour une utilisation chez les nourrissons dès l’âge de six semaines contre les infections invasives à méningocoques
04/08/2026
MenQuadfi de Sanofi approuvé dans l’UE pour une utilisation chez les nourrissons dès l’âge de six semaines contre les infections invasives à méningocoques Paris, le 4 août 2026. Sanofi a annoncé aujourd’hui que la [...]
Rapid Nutrition Joins Global Conversation on the Future of AI-Driven HealthTech
04/08/2026
Growing recognition across leading international business media highlights increasing interest in the convergence of artificial intelligence, personalized wellness and digital health. LONDON, Aug. 03, 2026 (GLOBE [...]
InnoCare Announces Orelabrutinib in Combination with Mesutoclax Granted Breakthrough Therapy Designation in China
04/08/2026
BEIJING, Aug. 03, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that orelabrutinib [...]
Dianthus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
04/08/2026
NEW YORK and WALTHAM, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the [...]
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/08/2026
SAN DIEGO, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib [...]
Direct Meds Expands DirectMax Patient Access and Prescription Fulfillment Information
03/08/2026
Direct Meds has expanded the patient information available for DirectMax, including its online clinical-review process, compounded-medication status, licensed-pharmacy fulfillment structure, recurring-plan terms and [...]
DentaBiome Details Oral Postbiotic Formula and Sourcing Amid 2026 Dental Caries Research
03/08/2026
Berry Frost chewable formula pairs Lactobacillus postbiotic strains, xylitol, cranberry extract and purple carrot powder in a GMP-certified US facility. Tallmadge, OH, Aug. 03, 2026 (GLOBE NEWSWIRE) -- These statements [...]
Apnimed Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
03/08/2026
CAMBRIDGE, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Apnimed, Inc. (Nasdaq: APMD) (“Apnimed”), a late stage clinical pharmaceutical company dedicated to the discovery, development and commercialization of novel oral [...]
CapsoVision® Announces International Launch of AI Highlights
03/08/2026
AI-assisted review feature designed to support physician review of small bowel capsule endoscopy studies using the CapsoCam Plus® system SARATOGA, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV [...]
Vireo Growth to Report Second Quarter 2026 Financial Results on August 11, 2026
03/08/2026
MINNEAPOLIS, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo” or the “Company”), today announced that the Company will host a conference call on Tuesday, August 11, 2026, at 8:00 a [...]
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
03/08/2026
BOSTON, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, on August 1, 2026, the Compensation [...]
Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors
03/08/2026
NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare is the former [...]
Dyadic to Report Q2 2026 Financial Results and Host Conference Call on Wednesday August 12, 2026
03/08/2026
JUPITER, Fla., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. d/b/a Dyadic Applied BioSolutions ("Dyadic", "we", "us", "our", or the "Company") (Nasdaq: DYAI), a global biotechnology company focused on the [...]

Pages